Selection Committee

Selection Committee



Comprises domestic and international experts with extensive knowledge and experience in research and development of drugs, vaccines, and diagnostics. The Selection Committee is the key decision-making body in reviewing applications and awarding investments in this area. This committee evaluates investment proposals and reports from development partners, and recommends investments to the Board of Directors.

Chairman

Paul Herrling

Former Head of Corporate Research at Novartis and the Chairman of the Board of the Novartis Institute for Tropical Diseases

Member

Ann Mills-Duggan

Partner, Innovations
Wellcome Trust


Member

Melissa Malhame

Vice President of Business Development
Adjuvance Technologies Inc.


Member

Christian Lienhardt

Research Director
French National Research Institute for Sustainable Development (IRD, Institut de Recherche pour le Développement)

Member

Gerald Voss

Executive Director
SciPeo Sprl, Science and People